Prices are adjusted according to historical splits.
- Today's Low:
- Today's High:
- Open Price:
- 52W Low:
- 52W High:
- Prev. Close:
- Market Cap.:
- $51.23 million
- Book Value:
- Revenue TTM:
- $83.16 million
- Operating Margin TTM:
- Gross Profit TTM:
- $43.13 million
- Profit Margin:
- Return on Assets TTM:
- Return on Equity TTM:
Vaso Corp had its IPO on 1988-10-24 under the ticker symbol VASO.
The company operates in the Healthcare sector and Health Information Services industry. Vaso Corp has a staff strength of 272 employees.
Shares of Vaso Corp opened at $0.29 at the start of the last trading session i.e. 2023-09-12.
The stocks traded within a range of $0.28 - $0.31, and closed at $0.29.
This is a -0.21% slip from the previous day's closing price.
A total volume of 215,708 shares were traded at the close of the day’s session.
In the last one week, shares of Vaso Corp have slipped by -0.21%.
Vaso Corp's Key Ratios
Vaso Corp has a market cap of $51.23 million, indicating a price to book ratio of 2.2748 and a price to sales ratio of 0.4319.
In the last 12-months Vaso Corp’s revenue was $83.16 million with a gross profit of $43.13 million and an EBITDA of $9.35 million. The EBITDA ratio measures Vaso Corp's overall financial performance and is widely used to measure its profitability.
In the trailing 12-month period, Vaso Corp’s operating margin was 9.79% while its return on assets stood at 8.01% with a return of equity of 70.67%.
In Q2, Vaso Corp’s quarterly earnings growth was a positive 15.6% while revenue growth was a positive 4.8%.
Vaso Corp’s PE and PEG Ratio
- Forward PE
- Trailing PE
Its diluted EPS in the last 12-months stands at $0.07 per share while it has a forward price to earnings multiple of 0 and a PEG multiple of 0. A low price to earnings ratio can mean the stock is attractively valued while a high ratio suggests the stock may be overvalued.
The PEG on the other hand provides a broader view compared to the P/E ratio and gives greater insight into Vaso Corp’s profitability.
Vaso Corp stock is trading at a EV to sales ratio of 0.2014 and a EV to EBITDA ratio of 1.509. Its price to sales ratio in the trailing 12-months stood at 0.4319.
Vaso Corp stock pays annual dividends of $0 per share, indicating a yield of 0% and a payout ratio of 0%.
Balance sheet and cash flow metrics
- Total Assets
- $73.58 million
- Total Liabilities
- $29.08 million
- Operating Cash Flow
- Capital Expenditure
- Dividend Payout Ratio
Vaso Corp ended 2023 with $73.58 million in total assets and $0 in total liabilities. Its intangible assets were valued at $73.58 million while shareholder equity stood at $25.23 million.
Vaso Corp ended 2023 with $16.73 million in deferred long-term liabilities, $29.08 million in other current liabilities, 185000.00 in common stock, $-36503000.00 in retained earnings and $15.56 million in goodwill. Its cash balance stood at $14.40 million and cash and short-term investments were $26.07 million. The company’s total short-term debt was $898,000 while long-term debt stood at $10000.00.
Vaso Corp’s total current assets stands at $42.97 million while long-term investments were $764000.00 and short-term investments were $11.68 million. Its net receivables were $10.27 million compared to accounts payable of $2.53 million and inventory worth $1.54 million.
In 2023, Vaso Corp's operating cash flow was $-3212000.00 while its capital expenditure stood at $212000.
Comparatively, Vaso Corp paid $0 in dividends in 2023.
Other key metrics
- Current Trading Price
- 52-Week High
- 52-Week Low
- Analyst Target Price
Vaso Corp stock is currently trading at $0.29 per share. It touched a 52-week high of $0.315 and a 52-week low of $0.315. Analysts tracking the stock have a 12-month average target price of $.
Its 50-day moving average was $0.28 and 200-day moving average was $0.24 The short ratio stood at 0 indicating a short percent outstanding of 0%.
Around 4456.5% of the company’s stock are held by insiders while 0% are held by institutions.
Frequently Asked Questions About Vaso Corp
Similar Industry Stocks (Health Information Services)
Vaso Corporation, together with its subsidiaries, operates in the healthcare equipment and information technology industries in the United States and internationally. The company operates through three segments: IT, Professional Sales Service, and Equipment. The IT segment primarily focuses on healthcare IT and managed network technology services. This segment offers managed diagnostic imaging applications, managed network infrastructure, managed network transport, and managed security services. The Professional Sales Service segment principally focuses on the sale of healthcare capital equipment for General Electric Healthcare (GEHC) into the health provider middle market. Its offerings include GEHC diagnostic imaging capital equipment, GEHC service agreements, GEHC training, and GEHC and third-party financial services. The Equipment segment primarily focuses on the design, manufacture, sale, and service of proprietary medical devices. This segment offers Biox series Holter monitors and ambulatory blood pressure recorders; ARCS series analysis, reporting, and communication software for ECG and blood pressure; MobiCare multi-parameter wireless vital-sign monitoring systems; and Enhanced External Counterpulsation therapy systems that are used for non-invasive, outpatient treatment of ischemic heart disease. The company was formerly known as Vasomedical, Inc. and changed its name to Vaso Corporation in November 2016. Vaso Corporation was incorporated in 1987 and is headquartered in Plainview, New York.